Abstract We conducted this study to report on our initial experience and assess the safety, feasibility, and efficacy of extraperitoneal single plus one port laparoscopic radical prostatectomy (SPOPL-RP), and determine whether it shows any objective advantage over standard laparoscopic radical prostatectomy. From June 2009 to September 2011, 15 extraperitoneal SPOPL-RPs were performed through a 2e3-cm subumbilical longitudinal incision and another 5-mm trocar placed at the McBurney point. This cohort was compared with 37 contemporary patients who underwent standard extraperitoneal laparoscopic radical prostatectomy performed by the same urologist. Peri-and postoperative outcomes, including continence, potency, and scar length, were statistically analyzed. The two groups were comparable with respect to patient demographics, estimated blood loss, drainage time, duration of catheterization, catheterization rate >14 days, complication rate, postoperative hospitalization, and postoperative functional and oncologic outcomes (p > 0.05). The SPOPL-RP procedures had a longer mean operative time (170.1 minutes vs. 139.5 minutes, p Z 0.005), but with fewer patients requiring analgesics (20% vs. 54.1%, p Z 0.038) and earlier resumption of oral intake (20.7 hours vs. 26.8 hours, p Z 0.037). The mean scar length in the SPOPL-RP group was much smaller (3.4 cm vs. 5.8 cm, p Z 0.000) owing to the significant reduction of the skin incision. The peri-and postoperative outcomes of SPOPL-RP for low-risk prostate cancer are comparable to those with the standard laparoscopic approach. In addition, SPOPL-RP provides better postoperative pain control, faster recovery of bowel function, and smaller scar length than standard laparoscopy, albeit with a longer operative time.
Introduction
Transperitoneal and extraperitoneal laparoscopic radical prostatectomy (LRP) have become the standard treatment for local prostate cancer (PCa) because of their minimal invasiveness, comparable operative duration, satisfactory pain control, short hospital stay, and quick postoperative convalescence [1e3] . Given the ongoing trend toward minimal invasiveness in urologic surgery, single-port laparoscopy (SPL) aims to further reduce the limited invasiveness of conventional laparoscopy and, at the same time, offer an even better cosmetic outcome and quicker postoperative convalescence with little pain [4] . However, SPL remains a challenging surgical technique mainly because of the lack of triangulation among the surgical instruments. Proper laparoscopic suturing techniques and considerable surgical skills are required for procedures such as radical prostatectomy, and proper suturing is mandatory to adequately complete the vesicourethral anastomosis. Meanwhile, there is a lack of sufficient scientific data to confirm whether this advanced technique is objectively superior to conventional laparoscopy.
In this 2-year retrospective cohort, we compared single plus one port laparoscopic radical prostatectomy (SPOPL-RP) using the strategy of gaining multi-instrument access through a single port with standard laparoscopies in an attempt to determine whether SPOPL had any objective advantage over standard laparoscopies with respect to perioperative outcomes and follow-up data.
Patients and methods

Study design and patients
In this retrospective case-control study, we compared patients who underwent either SPOPL-RP or standard LRP beginning with our initial SPOPL-RP case in June 2009. Between June 2009 and September 2011, a total of 96 LRP procedures were performed by a single surgeon (Dr Danfeng Xu). Patients who had received preoperative pharmacotherapy, radiotherapy preoperatively, or intraoperative positive lymph node were excluded.
Indications for LRP were generally the same as those for open prostatectomy, and patients with clinical stage T1ce2c PCa with a life expectancy of >10 years were candidates for LRP. Preoperative computed tomography and magnetic resonance imaging examinations of the pelvic cavity showed no sign of metastasis, and radionuclide bone scans showed no bone metastasis in any of the included patients.
Of the 96 patients, we identified 81 patients who were treated with standard LRP and 15 patients who were treated with SPOPL-RP for early stage local PCa. The perioperative and 24-month follow-up outcomes of the SPOPL group (n Z 15) were compared with the outcomes of 37 matched patients who were treated with standard LRP during the same period. Patients in the two groups were matched retrospectively on the basis of patient age, body mass index (BMI), American Society of Anesthesiologists score, preoperative serum prostate specific antigen (PSA) value, Gleason score, prostate size, preoperative continence, potency, and clinical tumor stage (cT1cecT2b). Patients were treated with either standard LRP or SPOPL-RP according to the clinical judgment of the surgeon. Criteria for SPOPL-RP that could provide surgeons with the deciding factors included local PCa in a relatively early stage (cT1cecT2b), preoperative serum PSA value < 20, Gleason score < 7 and primary Gleason score < 3, relatively low BMI (<30), and no previous abdominal surgery. Meanwhile, patients with PCa at clinical stage > T2b, distant metastasis, serious comorbid disease, and that have been followed up for <1 year were excluded. Patients were informed that additional incisions or open surgical conversions might be warranted during the procedure. All patients provided informed consent.
Perioperative outcomes and follow-up data
Patient demographics and perioperative data were reviewed, including operative time, estimated blood loss, transfusion rate, pre-and postoperative serum levels of hemoglobin, surgical conversions, analgesic requirement, time off of oral intake, scar length, drainage and catheterization time, pathologic results, positive surgical margin (PSM) rate and the location of þSM, postoperative hospitalization length, intra-and postoperative complications (according to the Clavien grading system [5] ), pre-and postoperative continence and potency rate, and short-to intermediate-term follow-up data. PSA and correlative image examinations after RP were carried out quarterly during the 1 st year and semiannually during the 2 nd year. Pre-and postoperative evaluations of continence and potency were performed in 52 patients using the International Continence Society questionnaire and the International Index of Erectile Function along with Sexual Encounter Profile (SEP) diaries. Potency and continence data were recorded at 3 months, 6 months, 12 months, and 24 months after the procedure. Patients not requiring any pads or those who required one pad for safety were defined as continent. A requirement for two to three pads daily in patients with normal physical activity (walking) was considered "mild incontinence", and that for more than three pads daily was deemed "incontinence". Patients who responded positively to the following SEP diary questions were defined as potent regardless of whether PDE-5 inhibitors were useddSEP2: "Were you able to insert your penis into your partner's vagina?"; SEP3: "Did your erections last long enough to have sexual intercourse?"; and SEP5: "Were you satisfied with this sexual experience?" [6] .
Surgical techniques of SPOPL-RP and standard LRP
The techniques of SPOPL-RP and standard LRP have been previously reported in detail in our article published in the Chinese Medical Journal (English edition) [7] . The main multiple instrument access port (including one 10-mm and two 5-mm trocars) was placed in the subumbilical via a 2.5-cm longitudinal incision (Fig. 1A ). This port was applied to insert major surgical instruments to carry out the operation. An additional port (one 5-mm trocar) was made at the McBurney point (Fig. 1B) to allow the assistant to help the operator, to reduce single-port laparoscopic operational difficulties, and for postoperative drainage. No posterior bladder neck reconstruction was undertaken during the procedure in our two groups of patients. No routine bilateral lymph node dissection was performed during RP in patients at low risk for lymph node metastasis (PSA < 10 ng/mL and biopsy Gleason Score (GS) < 7)
Statistical analysis
The two groups were analyzed using ManneWhitney and Chi-square tests for continuous and categorical variables. Statistical significance was set at p < 0.05, and all reported p values were two-sided. Statistical analyses were performed using SPSS v. 18.0 (SPSS, Inc., Chicago, IL, USA).
Results
The preoperative patient characteristics are shown in Table  1 . The patient demographics were comparable between the two groups with respect to patient age, BMI, American Society of Anesthesiologists classification, serum PSA, highest Gleason biopsy, prostate size, clinical tumor stage, preoperative potency, and continence.
Surgical characteristics, pathologic outcomes, and followup data are presented in Table 2 . No surgical conversion was required in either group. No significant difference was observed in estimated blood loss, transfusion, postoperative hemoglobin, drainage time, duration of catheterization, catheterization rate >14 days, complication rate, length of postoperative hospital stay, PSMs, pathological stage, regional lymph node metastasis rate, biochemical-free status rate, and postoperative potent and continent rate between the SPOPL-RP and standard LRP groups. Compared with the standard LRP, the SPOPL-RP procedures required a longer mean operative time (170.1 minutes vs. 139.5 minutes, p Z 0.005), but with fewer patients requiring analgesics (20% vs. 54.1%, p Z 0.038) and earlier resumption of oral intake (20.7 hours vs. 26.8 hours, p Z 0.037). The mean scar length in the laparoendoscopic single-site (LESS) group was 3.4 cm compared with 5.8 cm (for five scars) in the standard laparoscopy group (p Z 0.000).
Transfusion was required in one case in the SPOPL-RP group owing to hemorrhage from an inadvertent injury of the lateral vascular pedicle of the prostate, and in two cases in the standard LRP group (Clavien grade II) owing to hemorrhage from the penile dorsal vascular complex, but no surgical conversion was needed in any of these three cases. Postoperative complications occurred in two patients in the SPOPL-RP group, including one patient with anastomotic urine leakage (Clavien grade II) and one patient with minor wound infection (Clavien grade I). In the standard laparoscopy group, anastomotic urine leakage occurred in two cases (Clavien grade II), urinary retention in one case (Clavien grade II), urethral stricture in one case (Clavien grade II), and minor wound infection in one case (Clavien grade I). Drainage, catheterization time, and length of hospital stay were prolonged in three cases of anastomotic urine leakage. Two cases of urethral stricture and urinary retention were treated with weekly urethral dilatation and catheterization. All postoperative complications were managed conservatively.
The continence results of both groups are indicated in Table 3 . In the SPOPL-RP group, 73.3% patients reported continence (0e1 pads/d), 13.3% patients reported minimal stress incontinence (2e3 pads/d), and 13.3% required >3 pads/d at 3 months after surgery, in comparison with 70.3%, 21.6%, and 8.1%, respectively, in the standard LRP group during the same period. At 6 months after surgery, 80% of patients in the SPOPL-RP group and 81.2% of patients in the standard LRP group reported continence. Mild stress incontinence was observed in 20% of patients in the SPOPL-RP group and in 13.5% of patients in the standard LRP group. The percentage of incontinent patients in the SPOPL-RP and standard LRP groups was 0% and 5.4% at 6 months, respectively. Continence, mild incontinence, and incontinence rates in the 12-month follow-up period were 93.3%, 6.7%, and 0%, respectively, for patients undergoing SPOPL-RP versus 86.5%, 10.8%, and 2.7%, respectively, for patients undergoing standard LRP. There were no incontinent patients at 24 months after surgery in either group, however, one patient in the SPOPL-RP group required 2e3 pads/d and three patients in the standard LRP group required 2e3 pads/d. No statistical significance was observed between the two groups. The mean follow-up duration of the SPOPL-RP and standard LRP groups was 34.5 AE 8.58 (range 24e51) months and 34.4 AE 7.12 (range 25e50) months, respectively. Erectile function sufficient for intercourse with or without the help of PDE-5 inhibitors at 3 months, 6 months, 12 months, and 24 months was reported in 33.3%, 40%, 53.3%, and 60%, respectively, of patients in the SPOPL-RP group, compared with 29.7%, 43.2%, 51.4%, and 62.2%, respectively, in the standard LRP group (Table 3) . The difference was not statistically significant.
The oncological data are presented in Table 2 . Although there were more patients with pT3a disease in the standard LRP group compared with the SPOPL-RP group, the difference was not statistically significant. The overall PSM rate was 13.3% in the SPOPL-RP group versus 16.2% in the standard LRP group; the difference was not statistically significant. The PSM was located in the apex in two patients and in the posterolateral aspect in two patients from the SPOPL-RP group. In the standard LRP group, the PSM was located in the apex in three patients, and in the apex, multiple sites, posterolateral aspect, and the base in each of the three patients. All eight PSM patients received hormone therapy thereafter. Regional lymph node metastasis was negative in both groups. The 24-month biochemicalfree status rate (PSA < 0.2 ng/mL) was 93.3% in the SPOPL-RP group and 94.6% in the standard LRP group with or without hormone therapy. No statistically significant difference was found between the two groups.
Discussion
When the first case of LRP was reported in 1997 in the United States, it was considered unfeasible because of the excessively long operating time [8] . In subsequent years, however, minimally invasive surgery was soon shown to be both reproducible and practical in Europe and became the standard of care [9e11]. Since then, the LRP technique has been widely accepted by more urologists, who report that the resultant oncological control and functional recoveries are comparable to those of open surgery performed in many high-volume centers throughout the world [12, 13] .
Laparoscopic radical prostatectomy has become a wellestablished alternative to open surgery [14] . Despite the success with conventional LRP, incisions ranging from 0.5 cm to 3 cm and four or five trocars are strictly required, although each incision runs the risk of potential portrelated complications. Efforts have been made to further reduce minimally invasive surgery-associated morbidity. SPL allows laparoscopic procedures to be performed through a single incision using a multichannel port and articulating instruments [15, 16] . In urology, SPL has been used to perform radical nephrectomy, partial nephrectomy, donor nephrectomy, adrenalectomy, renal cryoablation, pyeloplasty, ureteroneocystostomy, radical cystectomy, varicocelectomy, prostatectomy, and robotic surgery [17e21].
Kaouk et al. [22] first reported a series of four laparoscopic radical prostatectomies for early-stage PCa using a single port in 2008. They used a multichannel port inserted transperitoneally through a 1.8-cm umbilical incision. No additional extraumbilical instrument or port was inserted, and urethrovesical anastomosis was performed using freehand interrupted suturing and extracorporeal knot tying. Their practice demonstrated that single-incision LRP is feasible and efficacious, thus providing a prototype platform for the evolution of natural orifice translumenal endoscopic surgery. Since 2009, Dr Xu in our surgical team has used SPOPL-RP in eight cases [7] . His practice was later modified by Wen et al. [23] , who recommended fixation of the two ends of the suture thread using double Lapro-Clips instead of the difficult knot tying. Since the introduction of robotic-assisted laparoscopic surgery in urology, it has been applied to LESS prostatectomy with initial pioneering experience [18, 24] . Despite the promising early outcomes, the true benefits of single-port LRP compared with standard laparoscopy are not clear, other than the subjective cosmetic outcomes [25] .
One related article reported by Akita et al. [26] made a comparison between two-port (umbilicus and left iliac fossa) laparoendoscopic and conventional five-port LRP and found that the two-port RP was associated with shorter operation time, less pain, shorter catheterization time, and quicker recovery of continence. An overview of other articles concerning comparisons between single-port and standard laparoscopic surgery in urology [20,27e29] , in combination with our own experience, shows the advantage of SPOPL-RPda reduced need for postoperative analgesics, faster postoperative recovery of bowel function, and smaller scar length. Although operative time in the SPOPL-RP group was significantly longer than that in the standard LRP, the mean operative time in our SPOPL-RP group was significantly shorter than that reported in other studies using the same extraperitoneal transumbilical procedure [23,26,30e33] , probably because we used another 5-mm trocar under direct vision at the McBurney point. The main limitation of single-port LRP is the reduced triangulation, which may cause clashing of the instruments owing to limited maneuverability, difficult visualization, and small exposure of the operative field. From our initial experience, these technical issues with single-port LRP can be partially resolved in our SPOPL-RP technique by placing another 5-mm trocar at the McBurney point [7] . To date, most comparative studies have shown a noninferiority of LESS over conventional laparoscopy with respect to perioperative outcomes and revealed an encouraging tendency toward decreased postoperative pain and better cosmesis [26, 34, 35] .
In the present study, we not only evaluated surgical safety, surgical feasibility, perioperative outcomes, postoperative functional outcomes, and oncologic outcomes, but also pain, recovery, and scar length to assess the advantages of SPOPL-RP in this patient group. The results have clearly demonstrated the advantages of SPOPL-RP, including a reduced need for postoperative analgesics, faster postoperative recovery of bowel function, and smaller scar length. However, these benefits need to be compared with the costs of technology.
Finally, this study is susceptible to all limitations inherent in any retrospective study, and it is important to recognize that LESS surgery is currently in an evolutionary phase. Owing to the relatively small number of patients in the SPOPL-RP cohort, even though we obtained statistically significant data, the actual benefits of SPOPL-RP versus standard laparoscopy remain to be proven. In addition, selection bias might still exist due to the clinical judgment of the surgeon, although all patients met our inclusion criteria. Furthermore, there are several subjective factors in our patient follow-up setup with respect to postoperative continence, and the pads used for solving daily urine incontinence in our study may be smaller than those used in other series, which may explain why the continence rate in our study was lower than that in other series.
Conclusion
The perioperative, postoperative functional, and oncologic outcomes of extraperitoneal SPOPL-RP for early-stage and local PCa are comparable with those in the standard laparoscopic approach. SPOPL-RP has proven to be able to provide better postoperative pain control, faster recovery of bowel function, and smaller scar length compared with standard laparoscopy, albeit with a longer operative time. However, additional researchdincluding randomized controlled trials with long-term follow-up periodsdis warranted to draw solid conclusions regarding the clinical validation of this procedure in comparison with standard laparoscopic approaches.
